Bithiazole metabolites from the myxobacterium Myxococcus fulvus SCIE SCOPUS
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Jong-Woong | - |
dc.contributor.author | Jang, Kyoung Hwa | - |
dc.contributor.author | Yang, Hyeong-Cheol | - |
dc.contributor.author | Oh, Ki-Bong | - |
dc.contributor.author | Lee, Hyi-Seung | - |
dc.contributor.author | Shin, Jongheon | - |
dc.date.accessioned | 2020-04-20T12:25:03Z | - |
dc.date.available | 2020-04-20T12:25:03Z | - |
dc.date.created | 2020-01-28 | - |
dc.date.issued | 2007-03 | - |
dc.identifier.issn | 0009-2363 | - |
dc.identifier.uri | https://sciwatch.kiost.ac.kr/handle/2020.kiost/4728 | - |
dc.description.abstract | Two new bithiazole metabolites (3, 4) along with the previously reported compounds (1, 2) were isolated from the culture broth of the gliding bacterium Myxococcus fulvus collected from a Korean soil. The structures of these compounds were determined to be analogous to myxothiazole A on the basis of combined spectroscopic analyses. The new compounds exhibited significant cytotoxicity and moderate antifungal activity against the mouse fibloblast cell-line L929 and Candida albicans, respectively. These data were consistent with the previous finding that the bioactivity of myxothiazoles was highly dependent on the presence of terminal methoxy enol functionality. | - |
dc.description.uri | 1 | - |
dc.language | English | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.subject | CYSTOBACTER-FUSCUS | - |
dc.subject | BIOLOGICAL-PROPERTIES | - |
dc.subject | RESPIRATORY-CHAIN | - |
dc.subject | MYXOTHIAZOL | - |
dc.subject | ANTIBIOTICS | - |
dc.subject | CYSTOTHIAZOLES | - |
dc.subject | BIOSYNTHESIS | - |
dc.title | Bithiazole metabolites from the myxobacterium Myxococcus fulvus | - |
dc.type | Article | - |
dc.citation.endPage | 479 | - |
dc.citation.startPage | 477 | - |
dc.citation.title | CHEMICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.volume | 55 | - |
dc.citation.number | 3 | - |
dc.contributor.alternativeName | 이희승 | - |
dc.identifier.bibliographicCitation | CHEMICAL & PHARMACEUTICAL BULLETIN, v.55, no.3, pp.477 - 479 | - |
dc.identifier.doi | 10.1248/cpb.55.477 | - |
dc.identifier.scopusid | 2-s2.0-34047179419 | - |
dc.identifier.wosid | 000245935200028 | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | CYSTOBACTER-FUSCUS | - |
dc.subject.keywordPlus | BIOLOGICAL-PROPERTIES | - |
dc.subject.keywordPlus | RESPIRATORY-CHAIN | - |
dc.subject.keywordPlus | MYXOTHIAZOL | - |
dc.subject.keywordPlus | ANTIBIOTICS | - |
dc.subject.keywordPlus | CYSTOTHIAZOLES | - |
dc.subject.keywordPlus | BIOSYNTHESIS | - |
dc.subject.keywordAuthor | myxobacterium | - |
dc.subject.keywordAuthor | myxothiazole | - |
dc.subject.keywordAuthor | antifungal activity | - |
dc.subject.keywordAuthor | cytotoxicity | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |